When Martin Schiller decided to launch his own company based off the research he did at UNLV, he picked Las Vegas despite the prospect of being one of only a handful of biotechnology firms in the valley.

Contrary to what many people think, there are only about 2,000 medicines approved by the Federal Drug Administration for people. And a quarter of those are biological products, or “biologics,” including vaccines, gene therapy, tissues and similar medicines—like insulin, for example.

Chastened by a series of economic downturns that punished the hospitality industry, state leaders are working to broaden the economy.

Your genes govern appearance and blood type, but they're also responsible for a whole lot more.

CRISPR reached a big milestone this year by treating a disease inside the body—here's what's next for the technology.

Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory. This joint project will make available the functional output of Variants of Unknown Significance throughout key portion of the ERBB2 gene through the JAX Clinical Knowledgebase, a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles.

Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory (JAX). This joint project will make available the functional output of Variants of Unknown Significance (VUS) throughout key portion of the ERBB2 gene through the JAX Clinical Knowledgebase (CKB), a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles.

The International Innovation Center @ Vegas (IIC@Vegas), a center for established and emerging tech companies developing smart technologies, announces a new tenant: Heligenics, Inc., a company founded to improve drug development, optimize clinical trial design and discover new diagnostics.